Martee Hensley
Cited by
Cited by
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
ND Kauff, JM Satagopan, ME Robson, L Scheuer, M Hensley, CA Hudis, ...
New England Journal of Medicine 346 (21), 1609-1615, 2002
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
TP Hughes, J Kaeda, S Branford, Z Rudzki, A Hochhaus, ML Hensley, ...
New England Journal of Medicine 349 (15), 1423-1432, 2003
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for …
RG Maki, JK Wathen, SR Patel, DA Priebat, SH Okuno, B Samuels, ...
J clin oncol 25 (19), 2755-2763, 2007
Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: results of a phase III randomized …
GD Demetri, M Von Mehren, RL Jones, ML Hensley, SM Schuetze, ...
Journal of Clinical Oncology 34 (8), 786, 2016
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial
ML Hensley, R Maki, E Venkatraman, G Geller, M Lovegren, ...
Journal of Clinical Oncology 20 (12), 2824-2831, 2002
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
DS Chi, EL Eisenhauer, J Lang, J Huh, L Haddad, NR Abu-Rustum, ...
Gynecologic oncology 103 (2), 559-564, 2006
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants
ML Hensley, KL Hagerty, T Kewalramani, DM Green, NJ Meropol, ...
Journal of clinical oncology 27 (1), 127-145, 2009
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas
RG Maki, DR D'Adamo, ML Keohan, M Saulle, SM Schuetze, SD Undevia, ...
Journal of Clinical Oncology 27 (19), 3133, 2009
A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies
C Aghajanian, S Soignet, DS Dizon, CS Pien, J Adams, PJ Elliott, ...
Clinical cancer research 8 (8), 2505-2511, 2002
Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers
L Scheuer, N Kauff, M Robson, B Kelly, R Barakat, J Satagopan, N Ellis, ...
Journal of Clinical Oncology 20 (5), 1260-1268, 2002
American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy Protectants
ML Hensley, LM Schuchter, C Lindley, NJ Meropol, GI Cohen, G Broder, ...
Journal of Clinical Oncology 17 (10), 3333-3355, 1999
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial
ML Hensley, JA Blessing, R Mannel, PG Rose
Gynecologic oncology 109 (3), 329-334, 2008
Identification of prognostic factors in advanced epithelial ovarian carcinoma
DS Chi, JB Liao, LF Leon, ES Venkatraman, ML Hensley, D Bhaskaran, ...
Gynecologic oncology 82 (3), 532-537, 2001
Patient online self-reporting of toxicity symptoms during chemotherapy
E Basch, D Artz, D Dulko, K Scher, P Sabbatini, M Hensley, N Mitra, ...
Journal of clinIcal oncology 23 (15), 3552-3561, 2005
Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients
P Sabbatini, T Tsuji, L Ferran, E Ritter, C Sedrak, K Tuballes, ...
Clinical cancer research 18 (23), 6497-6508, 2012
Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging
CH Kim, RA Soslow, KJ Park, EL Barber, F Khoury-Collado, JN Barlin, ...
International Journal of Gynecologic Cancer 23 (5), 2013
2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.
LM Schuchter, ML Hensley, NJ Meropol, EP Winer
Journal of clinical oncology: official journal of the American Society of …, 2002
Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study
EA Hahn, GA Glendenning, MV Sorensen, SA Hudgens, BJ Druker, ...
Journal of Clinical Oncology 21 (11), 2138-2146, 2003
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study
ML Hensley, JA Blessing, K DeGeest, O Abulafia, PG Rose, HD Homesley
Gynecologic oncology 109 (3), 323-328, 2008
Imatinib treatment: specific issues related to safety, fertility, and pregnancy
ML Hensley, JM Ford
Seminars in hematology 40, 21-25, 2003
The system can't perform the operation now. Try again later.
Articles 1–20